Pyrroloquinoline quinone modulates YAP-related anti-ferroptotic activity to protect against myocardial hypertrophy

Background: Pyrroloquinoline quinone (PQQ) has been reported to exhibit cardioprotective and antioxidant activities. Accordingly, this study was developed to explore the effects of PQQ treatment on myocardial hypertrophy and the underlying mechanism of action governing any observed beneficial effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jiabin, Yu, Tao, Wu, Gujie, Xu, Peng, Wang, Chen, Su, Yiling, Wang, Li, Lu, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552946/
https://www.ncbi.nlm.nih.gov/pubmed/36238573
http://dx.doi.org/10.3389/fphar.2022.977385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552946/
https://www.ncbi.nlm.nih.gov/pubmed/36238573
http://dx.doi.org/10.3389/fphar.2022.977385

Ejemplares similares